{
    "code": "01042214",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01042214",
    "time": "2023-02-17 03:13:29",
    "許可證字號": "衛署藥製字第042214號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/04\/30",
    "發證日期": "87\/04\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00104221403",
    "中文品名": "普膚乳膏50毫克\/公克（杜西平）",
    "英文品名": "ICHDERM CREAM 50MG\/GM &quot;M.S.&quot;(DOXEPIN)",
    "適應症": "成人濕疹性皮膚炎（如異位性皮膚炎或單純性慢性苔癬）所致中度搔養症之短期治療。",
    "劑型": "363乳膏劑",
    "包裝": "瓶裝 軟管裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DOXEPIN HCL",
    "限制項目": "01國　產",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "0202114300  十全實業股份有限公司",
            "製造廠廠址": "南投縣南投市仁和路２７號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816600610",
            "成分名稱": "DOXEPIN HCL",
            "含量描述": "50",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "ArtworkProof_CompID_18477_Round_2_ARTDB017426L-109-04-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=010&Type=9"
        },
        {
            "title": "ARTDB017161L Doxepin HCl 50mg (CMO-TW) 8g Label-109-04-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=009&Type=9"
        },
        {
            "title": "ARTDB016521P Doxepin HCI 50mg (CMO-TW) PIL-109-04-10(廠商自行上傳).PDF",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=008&Type=9"
        },
        {
            "title": "ARTDB016520L Doxepin HCI 50mg (CMO-TW) 8g Tube-109-04-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=007&Type=9"
        },
        {
            "title": "ARTDB016518L Doxepin HCI 50mg (CMO-TW) 15g Tube-109-04-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=006&Type=9"
        },
        {
            "title": "MEICH01 普膚仿單-107-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=005&Type=9"
        },
        {
            "title": "010422140004.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=004&Type=9"
        },
        {
            "title": "ArtworkProof_CompID_18476_Round_1_ARTDB017425C_ok-109-04-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=005&Type=8"
        },
        {
            "title": "MTICH15 普膚15g Tube 19x120-107-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=004&Type=8"
        },
        {
            "title": "MLICH03 普膚乳膏15g-50 盒裝貼標-107-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=003&Type=8"
        },
        {
            "title": "MLICH01-普膚乳膏500mg瓶貼-107-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=002&Type=8"
        },
        {
            "title": "_A5FEADB6B6C7AF75A643A64C_-107-01-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01042214&Seq=001&Type=8"
        }
    ]
}